Unofficial; not affiliated with the European Commission. Source: European Commission, EU Funding & Tenders Portal. Reused under the Commission's reuse policy (Decision 2011/833/EU, CC BY 4.0); we reorganise the facts and add counts.
Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
Development of monoclonal antibodies to prevent and treat infections from Flaviviruses (HORIZON-HLTH-2027-01-DISEASE-06) is a forthcoming funding topic under Horizon Europe with a stated budget of €37.3 million. The next deadline is , 122 days away as of . It is planned to open on .
In our daily copy of EU Funding & Tenders Portal data (), 9 other topics in call HORIZON-HLTH-2027-01 are listed; Horizon Europe has 376 open or forthcoming calls here; the median stated budget for Horizon Europe calls is €12 million; 41 Horizon Europe calls have a deadline in February 2027.
| Identifier | HORIZON-HLTH-2027-01-DISEASE-06 |
|---|---|
| Programme | Horizon Europe |
| Status | Forthcoming |
| Opening date | |
| Deadline | |
| Submission | Single-stage |
| Type of action | Horizon Europe Research and Innovation Actions |
| Budget | €37.3 million (2027 budget) |
| Expected number of grants | 4 |
| EU contribution per project | €9 million to €10 million |
| Call | HORIZON-HLTH-2027-01 — Cluster 1 - Health (Single stage - 2027/1) |
| Themes on this site | Health |
| Cross-cutting priorities (portal) | Cooperation with partners from ASEAN, Africa, Digital Agenda, Social Innovation, Artificial Intelligence, International Cooperation |
| Portal keywords | Clinical development, Phase I, Clinical trials, Dengue, Disease control, Drug development, clinical phases, Emerging Epidemics, Epidemiology, Infectious diseases, Public health and epidemiology, Viruses |
Read the official topic page on the EU Funding & Tenders Portal
Type of action
Research and innovation actions fund new knowledge or the feasibility of a new technology, product or service. They usually need a consortium of partners from several countries.
Deadline
Deadline as published: . Check the official page for the exact time and any changes; late submissions are not accepted.
Next steps
- Open the official topic page and read the conditions, the call document and the evaluation criteria.
- Create a free EU Login and register your organisation to get a PIC, if you do not have one.
- Find partners if the topic needs a consortium (the portal's partner search is free).
- Start a draft in the submission system from the topic page and submit before the deadline.
New to EU funding? Read how to apply for EU funding.
Related calls
- Addressing disabilities through the life course to support independent living and inclusion — HORIZON-HLTH-2027-01-STAYHLTH-01, next deadline
- Development of cell-free protein synthesis platforms for discovery and/or production of biologicals — HORIZON-HLTH-2027-01-IND-01, next deadline
- Development of innovative antimicrobials against pathogens resistant to antimicrobials — HORIZON-HLTH-2027-01-DISEASE-08, next deadline
- Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses — HORIZON-HLTH-2027-01-DISEASE-07, next deadline
- Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential — HORIZON-HLTH-2027-01-DISEASE-05, next deadline
- Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change — HORIZON-HLTH-2027-01-ENVHLTH-02, next deadline
- Biotechnology for Healthy Ageing — HORIZON-EIC-2026-PATHFINDERCHALLENGES-01-02, next deadline
- Development of innovative tools, processes, equipment and technologies through responses to disasters and emergencies for search and rescue in hazardous conditions — HORIZON-CL3-2026-01-DRS-03, next deadline
- Multi-hazard approach and cumulative / cascading impacts — HORIZON-CL3-2026-01-DRS-02, next deadline
- Open topic on driving innovation uptake of disaster risk solutions — HORIZON-CL3-2026-01-DRS-04, next deadline